toggle

Karyopharm Therapeutics Inc.

Latest Karyopharm Therapeutics Inc. News and Updates

Karyopharm Therapeutics Gains on FDA Nod for XPOVIO

Yesterday, Karyopharm Therapeutics announced that it had received FDA approval for the first and only nuclear export inhibitor, XPOVIO.

ABOUT Market Realist
About Us
Privacy Policy
Terms of Use
DMCA

CONNECT with Market Realist

© Copyright 2022 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.